Author:
Lange-Asschenfeldt Christian,Benkert Otto
Publisher
Springer Berlin Heidelberg
Reference35 articles.
1. Alsubaie N, Al-Kuraishy HM, Al-Gareeb AI et al (2022) Statins use in Alzheimer disease: bane or boon from frantic search and narrative review. Brain Sci 12(10):1290
2. Bartels C, Wagner M, Wolfsgruber S et al (2018) Impact of SSRI Therapy on risk of conversion from mild cognitive impairment to Alzheimer’s dementia in individuals with previous depression. Am J Psychiatry 175(3):232–241
3. Battle CE, Abdul-Rahim AH, Shenkin SD et al (2021) Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis. Cochrane Database Syst Rev 2(2):CD13306
4. Bazzari FH, Bazzari AH (2022) BACE1 Inhibitors for Alzheimer’s disease: the past, present and any future? Molecules 27(24):8823
5. Christl J, Verhülsdonk S, Pessanha F et al (2019) Association of cerebrospinal fluid S100B protein with core biomarkers and cognitive deficits in prodromal and mild Alzheimer’s disease. J Alzheimers Dis 4:1119–1127